부산대학교 도서관

Prudon, N.; Cordero-Espinoza, L.; Morel, C.; Lepleux, M.; Gurchenkov, B.; Abarkan, M.; Milvoy, L.; Morand, P.; Moncaubeig, F.; Wurtz, H.; Poinçot, L.; Demarco, M.; Jonckeau, A.; Plétenka, J.; Luquet, E.; Fidalgo, M. Lanero; Dabee, G.; Dufourd, T.; Schroeder, J.; Alessandri, K.; Feyeux, M.; Bezard, E.; Faggiani, E.

Parkinsonism and Related Disorders. 122

Pignata A; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France.; Frieser D; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France.; Gonzalez-Fierro C; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France.; Hsiao CC; Neuroimmunology Research Group, Netherlands Institute for Neuroscience, 1105 BA Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam institute for Immunology and Infectious Diseases, Amsterdam University Medical Centers, 1105 AZ Amsterdam, Netherlands.; Engelenburg HJ; Neuroimmunology Research Group, Netherlands Institute for Neuroscience, 1105 BA Amsterdam, Netherlands.; Alis M; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France.; Fijalkow I; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France.; Cazaentre V; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France.; Nozeran L; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France.; Miranda-Capet R; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France.; Dufourd E; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France.; Vermeulen T; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France.; Aïda A; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France.; Le Coz C; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France.; Van Gisbergen K; Physiology and Cancer Programme, Champalimaud Research, Champalimaud Foundation, 1400-038 Lisbon, Portugal.; Blanchard N; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France.; Hamann J; Neuroimmunology Research Group, Netherlands Institute for Neuroscience, 1105 BA Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam institute for Immunology and Infectious Diseases, Amsterdam University Medical Centers, 1105 AZ Amsterdam, Netherlands.; Smolders J; Neuroimmunology Research Group, Netherlands Institute for Neuroscience, 1105 BA Amsterdam, Netherlands.; MS Center ErasMS, Departments of Neurology and Immunology, Erasmus Medical Center, 3015 GD Rotterdam, Netherlands.; Liblau RS; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France.; Department of Immunology, Toulouse University Hospitals, 31300 Toulouse, France.; Masson F; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Feyeux, M.; Cordero-Espinoza, L.; Milvoy, L.; Morand, P.; Morel, C.; Abarkan, M.; Husson, M.; Luquet, E.; Fidalgo, M. Lanero; De Marco, M.; Poincot, L.; Jonckeau, A.; Jamet, E.; Cesari, M.; Wurtz, H.; Pletenka, J.; Miternique, L.; Moisan, K.; Manache-Alberici, L.; Piouceau, L.; Guilbert, S.; Gurchenkov, B.; Lepleux, M.; Dufourd, T.; Prudon, N.; Moutier, V.; Moncaubeig, F.; Faggiani, E.

Cytotherapy. 25(6):S277-S277

Chartier C.; Ravinet N.; Bosco A.; Dufourd E.; Gadanho M.; Chauvin A.; Charlier J.; Maurelli M. P.; Cringoli G.; Rinaldi L.

Journal of Helminthology. 94

Rinaldi, L; Amadesi, A; Dufourd, E; Bosco, A; Gadanho, M; Lehebel, A; Maurelli, MP; Chauvin, A; Charlier, J; Cringoli, G; Ravinet, N; Chartier, C.

Rinaldi L.; Amadesi A.; Dufourd E.; Bosco A.; Gadanho M.; Lehebel A.; Maurelli M. P.; Chauvin A.; Charlier J.; Cringoli G.; Ravinet N.; Chartier C.

Parasit Vectors
Parasites & Vectors, Vol 12, Iss 1, Pp 1-8 (2019)
Parasites and Vectors 1 (12), . (2019)

Lalor R; Molecular Parasitology Laboratory, Centre of one Health (COH) and Ryan Institute, School of Natural Science, University of Galway, Galway, Ireland.; Tanaka A; School of Life Sciences, University of Technology Sydney, Sydney, Australia.; Shiels J; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.; Dixit A; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.; Hoadley S; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.; Dufourd E; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.; Hamon S; Molecular Parasitology Laboratory, Centre of one Health (COH) and Ryan Institute, School of Natural Science, University of Galway, Galway, Ireland.; To J; School of Life Sciences, University of Technology Sydney, Sydney, Australia.; Taggart CC; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.; Weldon S; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.; O'Brien B; School of Life Sciences, University of Technology Sydney, Sydney, Australia.; Greer J; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.; Dalton JP; Molecular Parasitology Laboratory, Centre of one Health (COH) and Ryan Institute, School of Natural Science, University of Galway, Galway, Ireland.; Donnelly S; Molecular Parasitology Laboratory, Centre of one Health (COH) and Ryan Institute, School of Natural Science, University of Galway, Galway, Ireland.; School of Life Sciences, University of Technology Sydney, Sydney, Australia.

Publisher: Federation of American Societies for Experimental Biology Country of Publication: United States NLM ID: 8804484 Publication Model: Print Cited Medium: Internet ISSN: 1530-6860 (Electronic) Linking ISSN: 08926638 NLM ISO Abbreviation: FASEB J Subsets: MEDLINE

M. Lambert; R. Jaulmes; A. Godin; E. Moliné; D. Dufourd

IFAC Proceedings Volumes. 40:421-426

Gonzalez-Fierro C; From the Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) (C.G.-F., C.F., E.D., V.C., G.M.-B., R.S.L., C.B.), University of Toulouse, CNRS, INSERM, UPS, France; Theodor Kocher Institute (S.A., B.E.), University of Bern, Switzerland; Laboratory of Immunology (R.R.C., B.X.), National Eye Institute, National Institutes of Health, Bethesda, MD; Department of Infectious and Tropical Diseases (G.M.-B.), Toulouse University Hospital, France; Auckland Cancer Society Research Centre (J.A.S.), Faculty of Medical and Health Sciences, The University of Auckland, New Zealand; Cancer Immunology Program (J.A.T.), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology (J.A.T.), The University of Melbourne, Parkville, Australia; Department of Neuroimmunology (J.B.), Center for Brain Research, Medical University of Vienna, Austria; and Department of Immunology (R.S.L., C.B.), Toulouse University Hospital, France.; Fonte C; From the Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) (C.G.-F., C.F., E.D., V.C., G.M.-B., R.S.L., C.B.), University of Toulouse, CNRS, INSERM, UPS, France; Theodor Kocher Institute (S.A., B.E.), University of Bern, Switzerland; Laboratory of Immunology (R.R.C., B.X.), National Eye Institute, National Institutes of Health, Bethesda, MD; Department of Infectious and Tropical Diseases (G.M.-B.), Toulouse University Hospital, France; Auckland Cancer Society Research Centre (J.A.S.), Faculty of Medical and Health Sciences, The University of Auckland, New Zealand; Cancer Immunology Program (J.A.T.), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology (J.A.T.), The University of Melbourne, Parkville, Australia; Department of Neuroimmunology (J.B.), Center for Brain Research, Medical University of Vienna, Austria; and Department of Immunology (R.S.L., C.B.), Toulouse University Hospital, France.; Dufourd E; From the Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) (C.G.-F., C.F., E.D., V.C., G.M.-B., R.S.L., C.B.), University of Toulouse, CNRS, INSERM, UPS, France; Theodor Kocher Institute (S.A., B.E.), University of Bern, Switzerland; Laboratory of Immunology (R.R.C., B.X.), National Eye Institute, National Institutes of Health, Bethesda, MD; Department of Infectious and Tropical Diseases (G.M.-B.), Toulouse University Hospital, France; Auckland Cancer Society Research Centre (J.A.S.), Faculty of Medical and Health Sciences, The University of Auckland, New Zealand; Cancer Immunology Program (J.A.T.), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology (J.A.T.), The University of Melbourne, Parkville, Australia; Department of Neuroimmunology (J.B.), Center for Brain Research, Medical University of Vienna, Austria; and Department of Immunology (R.S.L., C.B.), Toulouse University Hospital, France.; Cazaentre V; From the Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) (C.G.-F., C.F., E.D., V.C., G.M.-B., R.S.L., C.B.), University of Toulouse, CNRS, INSERM, UPS, France; Theodor Kocher Institute (S.A., B.E.), University of Bern, Switzerland; Laboratory of Immunology (R.R.C., B.X.), National Eye Institute, National Institutes of Health, Bethesda, MD; Department of Infectious and Tropical Diseases (G.M.-B.), Toulouse University Hospital, France; Auckland Cancer Society Research Centre (J.A.S.), Faculty of Medical and Health Sciences, The University of Auckland, New Zealand; Cancer Immunology Program (J.A.T.), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology (J.A.T.), The University of Melbourne, Parkville, Australia; Department of Neuroimmunology (J.B.), Center for Brain Research, Medical University of Vienna, Austria; and Department of Immunology (R.S.L., C.B.), Toulouse University Hospital, France.; Aydin S; From the Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) (C.G.-F., C.F., E.D., V.C., G.M.-B., R.S.L., C.B.), University of Toulouse, CNRS, INSERM, UPS, France; Theodor Kocher Institute (S.A., B.E.), University of Bern, Switzerland; Laboratory of Immunology (R.R.C., B.X.), National Eye Institute, National Institutes of Health, Bethesda, MD; Department of Infectious and Tropical Diseases (G.M.-B.), Toulouse University Hospital, France; Auckland Cancer Society Research Centre (J.A.S.), Faculty of Medical and Health Sciences, The University of Auckland, New Zealand; Cancer Immunology Program (J.A.T.), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology (J.A.T.), The University of Melbourne, Parkville, Australia; Department of Neuroimmunology (J.B.), Center for Brain Research, Medical University of Vienna, Austria; and Department of Immunology (R.S.L., C.B.), Toulouse University Hospital, France.; Engelhardt B; From the Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) (C.G.-F., C.F., E.D., V.C., G.M.-B., R.S.L., C.B.), University of Toulouse, CNRS, INSERM, UPS, France; Theodor Kocher Institute (S.A., B.E.), University of Bern, Switzerland; Laboratory of Immunology (R.R.C., B.X.), National Eye Institute, National Institutes of Health, Bethesda, MD; Department of Infectious and Tropical Diseases (G.M.-B.), Toulouse University Hospital, France; Auckland Cancer Society Research Centre (J.A.S.), Faculty of Medical and Health Sciences, The University of Auckland, New Zealand; Cancer Immunology Program (J.A.T.), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology (J.A.T.), The University of Melbourne, Parkville, Australia; Department of Neuroimmunology (J.B.), Center for Brain Research, Medical University of Vienna, Austria; and Department of Immunology (R.S.L., C.B.), Toulouse University Hospital, France.; Caspi RR; From the Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) (C.G.-F., C.F., E.D., V.C., G.M.-B., R.S.L., C.B.), University of Toulouse, CNRS, INSERM, UPS, France; Theodor Kocher Institute (S.A., B.E.), University of Bern, Switzerland; Laboratory of Immunology (R.R.C., B.X.), National Eye Institute, National Institutes of Health, Bethesda, MD; Department of Infectious and Tropical Diseases (G.M.-B.), Toulouse University Hospital, France; Auckland Cancer Society Research Centre (J.A.S.), Faculty of Medical and Health Sciences, The University of Auckland, New Zealand; Cancer Immunology Program (J.A.T.), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology (J.A.T.), The University of Melbourne, Parkville, Australia; Department of Neuroimmunology (J.B.), Center for Brain Research, Medical University of Vienna, Austria; and Department of Immunology (R.S.L., C.B.), Toulouse University Hospital, France.; Xu B; From the Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) (C.G.-F., C.F., E.D., V.C., G.M.-B., R.S.L., C.B.), University of Toulouse, CNRS, INSERM, UPS, France; Theodor Kocher Institute (S.A., B.E.), University of Bern, Switzerland; Laboratory of Immunology (R.R.C., B.X.), National Eye Institute, National Institutes of Health, Bethesda, MD; Department of Infectious and Tropical Diseases (G.M.-B.), Toulouse University Hospital, France; Auckland Cancer Society Research Centre (J.A.S.), Faculty of Medical and Health Sciences, The University of Auckland, New Zealand; Cancer Immunology Program (J.A.T.), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology (J.A.T.), The University of Melbourne, Parkville, Australia; Department of Neuroimmunology (J.B.), Center for Brain Research, Medical University of Vienna, Austria; and Department of Immunology (R.S.L., C.B.), Toulouse University Hospital, France.; Martin-Blondel G; From the Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) (C.G.-F., C.F., E.D., V.C., G.M.-B., R.S.L., C.B.), University of Toulouse, CNRS, INSERM, UPS, France; Theodor Kocher Institute (S.A., B.E.), University of Bern, Switzerland; Laboratory of Immunology (R.R.C., B.X.), National Eye Institute, National Institutes of Health, Bethesda, MD; Department of Infectious and Tropical Diseases (G.M.-B.), Toulouse University Hospital, France; Auckland Cancer Society Research Centre (J.A.S.), Faculty of Medical and Health Sciences, The University of Auckland, New Zealand; Cancer Immunology Program (J.A.T.), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology (J.A.T.), The University of Melbourne, Parkville, Australia; Department of Neuroimmunology (J.B.), Center for Brain Research, Medical University of Vienna, Austria; and Department of Immunology (R.S.L., C.B.), Toulouse University Hospital, France.; Spicer JA; From the Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) (C.G.-F., C.F., E.D., V.C., G.M.-B., R.S.L., C.B.), University of Toulouse, CNRS, INSERM, UPS, France; Theodor Kocher Institute (S.A., B.E.), University of Bern, Switzerland; Laboratory of Immunology (R.R.C., B.X.), National Eye Institute, National Institutes of Health, Bethesda, MD; Department of Infectious and Tropical Diseases (G.M.-B.), Toulouse University Hospital, France; Auckland Cancer Society Research Centre (J.A.S.), Faculty of Medical and Health Sciences, The University of Auckland, New Zealand; Cancer Immunology Program (J.A.T.), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology (J.A.T.), The University of Melbourne, Parkville, Australia; Department of Neuroimmunology (J.B.), Center for Brain Research, Medical University of Vienna, Austria; and Department of Immunology (R.S.L., C.B.), Toulouse University Hospital, France.; Trapani JA; From the Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) (C.G.-F., C.F., E.D., V.C., G.M.-B., R.S.L., C.B.), University of Toulouse, CNRS, INSERM, UPS, France; Theodor Kocher Institute (S.A., B.E.), University of Bern, Switzerland; Laboratory of Immunology (R.R.C., B.X.), National Eye Institute, National Institutes of Health, Bethesda, MD; Department of Infectious and Tropical Diseases (G.M.-B.), Toulouse University Hospital, France; Auckland Cancer Society Research Centre (J.A.S.), Faculty of Medical and Health Sciences, The University of Auckland, New Zealand; Cancer Immunology Program (J.A.T.), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology (J.A.T.), The University of Melbourne, Parkville, Australia; Department of Neuroimmunology (J.B.), Center for Brain Research, Medical University of Vienna, Austria; and Department of Immunology (R.S.L., C.B.), Toulouse University Hospital, France.; Bauer J; From the Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) (C.G.-F., C.F., E.D., V.C., G.M.-B., R.S.L., C.B.), University of Toulouse, CNRS, INSERM, UPS, France; Theodor Kocher Institute (S.A., B.E.), University of Bern, Switzerland; Laboratory of Immunology (R.R.C., B.X.), National Eye Institute, National Institutes of Health, Bethesda, MD; Department of Infectious and Tropical Diseases (G.M.-B.), Toulouse University Hospital, France; Auckland Cancer Society Research Centre (J.A.S.), Faculty of Medical and Health Sciences, The University of Auckland, New Zealand; Cancer Immunology Program (J.A.T.), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology (J.A.T.), The University of Melbourne, Parkville, Australia; Department of Neuroimmunology (J.B.), Center for Brain Research, Medical University of Vienna, Austria; and Department of Immunology (R.S.L., C.B.), Toulouse University Hospital, France.; Liblau RS; From the Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) (C.G.-F., C.F., E.D., V.C., G.M.-B., R.S.L., C.B.), University of Toulouse, CNRS, INSERM, UPS, France; Theodor Kocher Institute (S.A., B.E.), University of Bern, Switzerland; Laboratory of Immunology (R.R.C., B.X.), National Eye Institute, National Institutes of Health, Bethesda, MD; Department of Infectious and Tropical Diseases (G.M.-B.), Toulouse University Hospital, France; Auckland Cancer Society Research Centre (J.A.S.), Faculty of Medical and Health Sciences, The University of Auckland, New Zealand; Cancer Immunology Program (J.A.T.), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology (J.A.T.), The University of Melbourne, Parkville, Australia; Department of Neuroimmunology (J.B.), Center for Brain Research, Medical University of Vienna, Austria; and Department of Immunology (R.S.L., C.B.), Toulouse University Hospital, France. roland.liblau@inserm.fr.; Bost C; From the Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) (C.G.-F., C.F., E.D., V.C., G.M.-B., R.S.L., C.B.), University of Toulouse, CNRS, INSERM, UPS, France; Theodor Kocher Institute (S.A., B.E.), University of Bern, Switzerland; Laboratory of Immunology (R.R.C., B.X.), National Eye Institute, National Institutes of Health, Bethesda, MD; Department of Infectious and Tropical Diseases (G.M.-B.), Toulouse University Hospital, France; Auckland Cancer Society Research Centre (J.A.S.), Faculty of Medical and Health Sciences, The University of Auckland, New Zealand; Cancer Immunology Program (J.A.T.), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology (J.A.T.), The University of Melbourne, Parkville, Australia; Department of Neuroimmunology (J.B.), Center for Brain Research, Medical University of Vienna, Austria; and Department of Immunology (R.S.L., C.B.), Toulouse University Hospital, France.

Publisher: Wolters Kluwer Health/Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101636388 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 2332-7812 (Electronic) Linking ISSN: 23327812 NLM ISO Abbreviation: Neurol Neuroimmunol Neuroinflamm Subsets: MEDLINE

Prudon, N.; Cordero-Espinoza, L.; Abarkan, M.; Gurchenkov, B.; Morel, C.; Lepleux, M.; De Luca, V.; Pujol, N.; Milvoy, L.; Morand, P.; Moncaubeig, F.; Wurtz, H.; Poincot, L.; Demarco, M.; Jonckeau, A.; Pletenka, J.; Luquet, E.; Schmit, K.; Piouceau, L.; Guilbert, S.; Manache-Alberici, L.; Lanero, M.; Dabee, G.; Dufourd, T.; Schroeder, J.; Alessandri, K.; Bezard, E.; Faggiani, E.; Feyeux, M.

MOVEMENT DISORDERS; SEP 2024, 39 pS386-pS386, 1p. Supplement: 1

Lebrun-Frenay, Christine; Moulignier, Antoine; Pierrot-Deseilligny, Charles; Benrabah, Rabah; Moreau, Thibault; Lubetzki, Catherine; Monchecourt, Francoise; Abboud, H.; Samad, F. Abdul; Abdulnayef, A.; Al Khedr, A.; Alchaar, H.; Amevigbe, J.; Angibaud, G.; Anne, O.; Artaud-Uriot, M. -S.; Ast, G.; Augustin, J.; Aupy, M.; Azais-Vuillemin, C.; Bailbe, M.; Barbaste, P.; Barres, P.; Belhadia, A.; Benrabah, R.; Berets, O.; Bergouignan, F. -X.; Bierme, T.; Bille-Turc, F.; Blanc, S.; Boisselier, C.; Bonnet, I.; Borsotti, J. -P.; van Nieuwenhuyse, C. Bossu; Bouchard, C.; Bouchareine, A.; Boudouresques, G.; Boulesteix, J. -M.; Boulu, P.; Bourghol, B.; Brassat, D.; Bredin, A.; Breteau, G.; Camu, W.; Carlander, B.; Casseron, W.; Castelnovo, G.; Chapuis, S.; Chartier, J. -P.; Chauplannaz, G.; Chaury, F.; Cherlet, C.; Clanet, M.; Clavelou, P.; Clerc, F.; Colamarino, R.; Contis, P.; Couratier, C.; Coustans, M.; Crauser, C.; Daluzeau, N.; De Bray, J. -M.; De Broucker, T.; De Burghgraeve, V.; De Facq, P.; De Seze, J.; Debouverie, M.; Defer, G.; Degaey, I.; Delassaux, S.; Delorme, J.; Denis, B.; Derache-Belpame, N.; Dereeper, O.; Dereux, S. -A.; Derouiche, F.; Devos, P.; Deyrolle, A. -M.; Dib, J.; Dib, M.; Dourneau-Lethiecq, M. C.; Doux, M.; Dufourd-Delalande, S.; Dujardin, M.; Dunac, A.; Durand, G.; Dussaux, P.; Eck, P.; Engles, A.; Feltin, M. -P.; Ferrier, A.; Fleury, M. -C.; Gaida, P.; Gal, O.; Gayou-Joyeux, A.; Gentil, A.; Geraud, G.; Gere, J.; Getenet, J. -C.; Giannesini, C.; Giraud, E.; Giraud, P.; Gras, P.; Griffie, G.; Gueganno-Roche, C.; Guennoc, A. -M.; Guilloton, L.; Guinot, H.; Guiraud-Chaumeil, C.; Guiziou, C.; Gurau-Vasilescu, C.; Guy-Renouil, N.; Hamon, J. -B.; Heinzlef, O.; Hemet-Francois, C.; Henlin, J. -L.; Homeyer, P.; Hourmant, P.; Hurtevent, J. -P.; Ille, O.; Josien, E.; Juhel, C.; Kalafat, M.; Kelfa-Testut, S.; Kopf, A.; Kpade, C. -P.; Lalisse, M.; Laplaud, D.; Lapras, J.; Larrieu, J. -L.; Lavernhe, G.; Layet, A.; Le Bayon, A.; Le Coz, P.; Lebrun-Frenay, C.; Leche, J.; Legout, A.; Lejeune, P.; Lemarquis, P.; Level, G.; Lizeretti, J.; Locuratolo, D.; Logak, M.; Louchart, P.; Louiset, P.; Lubeau, M.; Mackowiak, A.; Magy, L.; Maillet-Vioud, M.; Mallecourt, J.; Mallecourt, C.; Marcel, S.; Mari, I.; Marrel, P.; Maupetit, J.; Medjbeur, S.; Menard, D.; Meynieu, P.; Minot-Myhie, M. -C.; Montagne, B.; Moreau, T.; Moreau, C.; Moulignier, A.; Muh, P.; Nkendjuo, J. -B.; Negre, A.; Neuschwander, P.; Neuville, V.; Nibbio, A.; Ollier, J.; Ondze, B.; Ouallet, J. -C.; Patte-Karsenti, N.; Pelletier, J.; Perrotte, P.; Pez, D.; Pierrot-Deseilligny, C.; Pin, J. -C.; Pittion-Vouyovitch, S.; Popescu, C.; Poujois, A.; Pouliquen, A.; Pouyet, A.; Remy, C.; Renglewicz-Destuynder, C.; Riche, G.; Rieu, L.; Robin, C.; Robinson, A.; Rosey-Dufosse, N.; Roualdes, B.; Rougie, M. -H.; Rouhart, F.; Ruggieri, I.; Saad, S.; Saintarailles, J.; Salandini-Roque, A. -M.; Salzmann, M.; Schmidt, N.; Senant, J.; Sergeant, T.; Seyeux, V.; Siboni, J.; Simon, O.; Stoquart-El Sankari, S.; Taurin, G.; Thibault-Tanchou, S.; Tillier, J. -N.; Tougeron, A.; Toureille-Borlet, L.; Tourniaire, P.; Touzani, H.; Trefouret, S.; Vandamme, X.; Vaunaize, J.; Viala, F.; Viola, U. -C.; Visy, J. -M.; Vlaicu-Bustuchina, M.; Vuillemet, F.; Wattier, V.; Wavreille, A.; Wegener, K.; Wiertlewski, S.; Zaenker, C.; Zephir-Thi, H.; Ziegler, F.; Copaxone Observ

JOURNAL OF NEUROLOGY; APR 2019, 266 4, p888-p901, 14p.

Girard V; Laboratory of Biology and Modelling of the Cell, UMR5239 CNRS, INSERM U 1210, ENS de Lyon, UMS 344 Biosciences Lyon Gerland, Université de Lyon, Lyon, France.; Goubard V; Laboratory of Biology and Modelling of the Cell, UMR5239 CNRS, INSERM U 1210, ENS de Lyon, UMS 344 Biosciences Lyon Gerland, Université de Lyon, Lyon, France.; Querenet M; Laboratory of Biology and Modelling of the Cell, UMR5239 CNRS, INSERM U 1210, ENS de Lyon, UMS 344 Biosciences Lyon Gerland, Université de Lyon, Lyon, France.; Seugnet L; Centre de Recherche en Neurosciences de Lyon, UMR5292, INSERM U1028, Equipe Physiologie Intégrée du Système d'éveil, Université Claude Bernard Lyon1, Lyon, France.; Pays L; CarMeN Laboratory, INSERM UMR-1060, INRA U1235, INSA of Lyon, Charles Merieux Medical School, Université Claude Bernard Lyon1, Université de Lyon, Lyon, France.; Banque de Tissus et de Cellules des Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France.; Nataf S; CarMeN Laboratory, INSERM UMR-1060, INRA U1235, INSA of Lyon, Charles Merieux Medical School, Université Claude Bernard Lyon1, Université de Lyon, Lyon, France.; Banque de Tissus et de Cellules des Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France.; Dufourd E; Laboratory of Biology and Modelling of the Cell, UMR5239 CNRS, INSERM U 1210, ENS de Lyon, UMS 344 Biosciences Lyon Gerland, Université de Lyon, Lyon, France.; Cluet D; Laboratory of Biology and Modelling of the Cell, UMR5239 CNRS, INSERM U 1210, ENS de Lyon, UMS 344 Biosciences Lyon Gerland, Université de Lyon, Lyon, France.; Mollereau B; Laboratory of Biology and Modelling of the Cell, UMR5239 CNRS, INSERM U 1210, ENS de Lyon, UMS 344 Biosciences Lyon Gerland, Université de Lyon, Lyon, France. bertrand.mollereau@ens-lyon.fr.; Institut Universitaire de France, Paris, France. bertrand.mollereau@ens-lyon.fr.; Davoust N; Laboratory of Biology and Modelling of the Cell, UMR5239 CNRS, INSERM U 1210, ENS de Lyon, UMS 344 Biosciences Lyon Gerland, Université de Lyon, Lyon, France. nathalie.davoust-nataf@ens-lyon.fr.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Dufourd J; Institut de Génétique Humaine, CNRS UMR9002, INSERM, Université de Montpellier, Equipe Labellisée la Ligue contre le cancer, 141 rue de la Cardonille, 34000 Montpellier, France.; Huynh THY; Institut de Génétique Humaine, CNRS UMR9002, INSERM, Université de Montpellier, Equipe Labellisée la Ligue contre le cancer, 141 rue de la Cardonille, 34000 Montpellier, France.; Sauzet S; Institut de Génétique Humaine, CNRS UMR9002, INSERM, Université de Montpellier, Equipe Labellisée la Ligue contre le cancer, 141 rue de la Cardonille, 34000 Montpellier, France.; Lai QH; University Côte d'Azur, CNRS UMR7284/INSERM U1081, Institute for Research on Cancer and Aging, Nice (IRCAN), Faculty of Medicine, Nice, France.; Abagnale F; University Côte d'Azur, CNRS UMR7284/INSERM U1081, Institute for Research on Cancer and Aging, Nice (IRCAN), Faculty of Medicine, Nice, France.; Zitouni S; Institut de Génétique Humaine, CNRS UMR9002, INSERM, Université de Montpellier, Equipe Labellisée la Ligue contre le cancer, 141 rue de la Cardonille, 34000 Montpellier, France.; Giraud-Panis MJ; University Côte d'Azur, CNRS UMR7284/INSERM U1081, Institute for Research on Cancer and Aging, Nice (IRCAN), Faculty of Medicine, Nice, France.; Urbach S; Institut de Génétique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.; Gilson E; University Côte d'Azur, CNRS UMR7284/INSERM U1081, Institute for Research on Cancer and Aging, Nice (IRCAN), Faculty of Medicine, Nice, France; Department of Medical Genetics, IHU RespirERA, CHU, Nice, France.; Tardat M; Institut de Génétique Humaine, CNRS UMR9002, INSERM, Université de Montpellier, Equipe Labellisée la Ligue contre le cancer, 141 rue de la Cardonille, 34000 Montpellier, France. Electronic address: mathieu.tardat@igh.cnrs.fr.; Déjardin J; Institut de Génétique Humaine, CNRS UMR9002, INSERM, Université de Montpellier, Equipe Labellisée la Ligue contre le cancer, 141 rue de la Cardonille, 34000 Montpellier, France. Electronic address: jerome.dejardin@igh.cnrs.fr.

Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Prudon N; Université de Bordeaux, CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France. Electronic address: nicolas.prudon@u-bordeaux.fr.; Cordero-Espinoza L; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Abarkan M; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Gurchenkov B; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Morel C; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Lepleux M; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; De Luca V; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Lartigue M; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Cabanas H; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Pujol N; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Milvoy L; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Morand P; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Moncaubeig F; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Wurtz H; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Poinçot L; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; De Marco M; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Jonckeau A; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Pletenka J; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Luquet E; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Sovera A; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Hardoüin J; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Neves IJ; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Machado-Hitau A; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Schmit K; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Piouceau L; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Guilbert S; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Manache-Alberici L; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Lanero Fidalgo M; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Dabée G; Université de Bordeaux, CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; PIV-EXPE, Centre Broca, Université de Bordeaux, F-33000 Bordeaux, France.; Dufourd T; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Schroeder J; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Alessandri K; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Bezard E; Université de Bordeaux, CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France.; Faggiani E; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.; Feyeux M; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.

Publisher: Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics Country of Publication: United States NLM ID: 101290381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-7479 (Electronic) Linking ISSN: 18787479 NLM ISO Abbreviation: Neurotherapeutics Subsets: MEDLINE

Dufourd T; Inserm, U1216, University Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France.; Robil N; Genosplice, Paris, France.; Mallet D; Inserm, U1216, University Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France.; Carcenac C; Inserm, U1216, University Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France.; Boulet S; Inserm, U1216, University Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France.; Brishoual S; CIC/CRB INSERM 1402, CHU de Poitiers, France.; Rabois E; CIC/CRB INSERM 1402, CHU de Poitiers, France.; Houeto JL; CIC/CRB INSERM 1402, CHU de Poitiers, France.; de la Grange P; Genosplice, Paris, France.; Carnicella S; Inserm, U1216, University Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France.

Publisher: Oxford University Press Country of Publication: England NLM ID: 101693064 Publication Model: eCollection Cited Medium: Internet ISSN: 2396-8923 (Electronic) Linking ISSN: 23968923 NLM ISO Abbreviation: Biol Methods Protoc Subsets: PubMed not MEDLINE

Pageaux, G.-P.; Nzinga, C.L.; Dorival, C.; Carrat, F.; Ganne, N.; Samuel, D.; Zoulim, F.; Cagnot, C.; Decaens, T.; Thabut, D.; Asselah, T.; Mathurin, P.; Habersetzer, F.; Bronowicki, J.-P.; Guyader, D.; Rosa, I.; Leroy, V.; Chazouilleres, O.; de Ledinghen, V.; Bourliere, M.; Causse, X.; Cales, P.; Metivier, S.; Loustaud-Ratti, V.; Riachi, G.; Alric, L.; Gelu-Simeon, M.; Minello, A.; Gournay, J.; Geist, C.; Tran, A.; Abergel, A.; Portal, I.; d’Alteroche, L.; Raffi, F.; Fontaine, H.; Pol, S.; Borsotti, J.-P.; Bossu-Van Nieuwenhuyse, C.; Bouffeteau, J.-C.; Bouillaguet, S.; Boukriche, Y.; Boulesteix, J.-M.; Bourre, B.; Brassat, D.; Bredin, A.; Brochet, B.; Brugeilles Baguelin, H.; Camara, O.; Camdessanche, J.-P.; Camu, W.; Carel, C.; Carlander, B.; Casez, O.; Chanel-Soulier, M.-P.; Chapuis, S.; Cimpoesu, M.; Ciron, J.; Clavelou, P.; Clerc, C.; Colamarino, R.; Couratier, C.; Courtois, S.; Creange, A.; Danielli, A.; De Broucker, T.; De Seze, J.; Defer, G.; Delorme, J.; Denis, B.; Derouiche, F.; Devos, P.; Deyrolle, A.-M.; Dib, M.; Dib, J.; Diot, E.; Doury, E.; Dufourd-Delalande, S.; Dupel-Pottier, C.; Dussaux, P.; Edan, G.; Edouard, T.; Escaillas, J.-P.; Ferriby, D.; Fouillet, N.; Fromager, G.; Gaida-Rostane, T.; Gaida, P.; Gal, G.; Garrigues, G.; Gayou-Joyeux, A.; Gentil, A.; Gerard, P.; Gere, J.; Gignoux, L.; Girard, P.; Giraud, P.; Gouttard, M.; Gras, P.; Guennoc, A.M.; Gugenheim, M.; Guilloton, L.; Hadjout, K.; Hautecoeur, P.; Hegbe, Y.; Heinzlef, O.; Henry, P.; Herve, Y.; Hijazi, J.; Homeyer, P.; Huttin, B.; Ille, O.; Jager, A.; Jomir, L.; Kardous, N.; Kerouanton, A.; Kpade, C.P.; Kubler, C.; Labauge, P.; Lallement, F.; Landragin, N.; Laplaud, D.A.; Laribi, H.; Lavernhe, G.; Le Biez, P.-É.; Le Bras, F.; Le Coz, P.; Leche, J.; Leder, S.J.; Legout, A.; Levasseur, M.; Lorenzi-Pernot, A.; Louchart, P.; Louillet, F.; Magy, L.; Maillard, S.; Maillart, E.; Maillet-Vioud, M.; Mallecourt-Emberger, C.; Manchon, É.; Mania, A.; Martinez-Almoyna, L.; Martinez, M.; Massengo, S.; Maugin, D.; Medjbeur, S.; Meliksetyan, G.; Menassa, M.; Meshaka-Dimitri-Boulos, D.; Mick, G.; Moreau, T.; Moulignier, A.; Mourand, I.; Muller, J.-P.; Neuschwander, P.; Nibbio, A.; Nifle, C.; Nkendjuo, J.-B.; Nokam Talom, G.; Ory, S.; Patry, I.; Pedespan, B.; Pelletier, J.; Pencu, D.-G.; Perrouty, B.; Peysson, S.; Popa-Coman, I.; Pouliquen, A.; Prat, C.; Prundean, A.; Radji, F.; Rakotoharinandrasana, H.T.; Razlog, L.; Remy, P.; Robin, C.; Rodier, G.; Romero, J.; Roualdes, B.; Rouhart, F.; Ruggieri, I.; Samad, F.A.; Sarafiant, I.; Schaeffer, S.; Schmidt, N.; Schuermans, P.; Seiller, N.; Soisson, T.; Sortais, A.; Stankoff, B.; Stefanizzi-Debuc, S.; Suchet, L.; Tardy, J.; Taurin, G.; Thabuy, F.; Theaudin, M.; Tilikete-Froment, C.; Tourbah, A.; Tourniaire, P.; Trefouret, S.; Vastene, M.; Verdure, P.; Vermersch, P.; Viala, F.; Videt-Gibou, D.; Vidry, E.; Vukusic, S.; Wagner, M.; Wattier, V.; Zaenker, C.; Ziegler, F.; Zola, J.-M.

In: BMC Infectious Diseases. (BMC Infectious Diseases, December 2022, 22(1))

Emerson, E. Allen; Sistla, A. Prasad; Bouyer, Patricia; Dufourd, Catherine; Fleury, Emmanuel; Petit, Antoine

Computer Aided Verification. 2000, p464-479. 16p.

Bouyer, P; Dufourd, C; Fleury, E; Petit, A

THEORETICAL COMPUTER SCIENCE; AUG 16 2004, 321 2-3, p291-p345, 55p.

Papeix C; Département de Neurologie, Hôpital de la Pitié Salpêtrière, APHP 6, 83 Boulevard de l'Hôpital, 75013, Paris, France. caroline.papeix@aphp.fr.; Castelnovo G; Service de Neurologie, CHU Carémeau, Nîmes, France.; Leray E; EHESP, Rennes, France.; Coustans M; Service de Neurologie, Hôpital Laënnec, Quimper, France.; Levy P; LEDa, LEGOS, Université Paris-Dauphine, PSL Research University, Paris, France.; Visy JM; Polyclinique de Courlancy, Reims, France.; Kobelt G; European Health Economics, Stockholm, Sweden.; Lamy F; Novartis Pharma S.A.S., Rueil-Malmaison, France.; Allaf B; Novartis Pharma S.A.S., Rueil-Malmaison, France.; Heintzmann F; Novartis Pharma S.A.S., Rueil-Malmaison, France.; Chouette I; Novartis Pharma S.A.S., Rueil-Malmaison, France.; Raponi E; Novartis Pharma S.A.S., Rueil-Malmaison, France.; Durand B; Novartis Pharma S.A.S., Rueil-Malmaison, France.; Grevat E; Novartis Pharma S.A.S., Rueil-Malmaison, France.; Kamar D; Ividata Life Science, Levallois-Perret, France.; Debouverie M; Service de Neurologie, CHU de Nancy, Nancy, France.; Lebrun-Frenay C; Service de Neurologie, UR2CA-URRIS, CRCSEP, Hôpital Pasteur 2, Nice, France.

Publisher: Springer Country of Publication: New Zealand NLM ID: 101637818 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8253 (Print) Linking ISSN: 21936536 NLM ISO Abbreviation: Neurol Ther Subsets: PubMed not MEDLINE

In Electronic Notes in Theoretical Computer Science 2 August 2004 98:89-104